Warfarin and clarithromycin should be used together with extreme caution and only under close medical supervision. Clarithromycin can significantly increase warfarin levels in the blood, raising the risk of serious or life-threatening bleeding. If your doctor prescribes both medications, your blood clotting time (INR) must be monitored closely, and your warfarin dose may need to be reduced.
The warfarin FDA label identifies clarithromycin as a significant interacting drug. According to warfarin prescribing information, macrolide antibiotics—the drug class to which clarithromycin belongs—are listed as agents that may potentiate the anticoagulant effect of warfarin. This means clarithromycin can make warfarin work more powerfully than intended, pushing INR values dangerously higher.
Clarithromycin's prescribing label similarly warns prescribers to use caution when co-administering with oral anticoagulants. The FDA's post-market surveillance database (FAERS—the Adverse Event Reporting System) contains documented cases of bleeding complications when macrolide antibiotics were combined with warfarin, particularly when doses were not adjusted or INR was not monitored.
No absolute contraindication exists between warfarin and clarithromycin, meaning the combination is not categorically forbidden—but it requires active management. This is a "significant" interaction that demands intervention from your pharmacist or physician before you fill the prescription.
To understand why clarithromycin and warfarin don't mix safely, you need to know how each drug is processed by your liver.
Warfarin is a vitamin K antagonist that works by blocking the production of clotting factors II, VII, IX, and X. It is metabolized almost entirely by the cytochrome P450 enzyme system in the liver, particularly by CYP2C9 and CYP3A4. These enzymes break down warfarin so your body can eliminate it. The rate at which your liver metabolizes warfarin determines its concentration in your blood—too slow, and warfarin accumulates; too fast, and you get inadequate anticoagulation.
Clarithromycin is a macrolide antibiotic used to treat bacterial respiratory tract infections, skin infections, and other infections. Critically, clarithromycin is a potent inhibitor of CYP3A4 and a moderate inhibitor of CYP2C9. When you take clarithromycin alongside warfarin, the antibiotic blocks the liver enzymes responsible for breaking down warfarin. This causes warfarin to accumulate in your bloodstream faster than it normally would be eliminated.
The result: higher warfarin concentrations lead to increased anticoagulant effect, which manifests as a rising INR (International Normalized Ratio—the standard measure of how long your blood takes to clot). An elevated INR means your blood is thinner and slower to clot. While that is the goal in some clinical situations, an excessive INR dramatically increases the risk of spontaneous or trauma-induced bleeding from wounds, gastrointestinal bleeding, intracranial hemorrhage, and other life-threatening events.
This enzyme inhibition begins within 24–48 hours of starting clarithromycin and can peak within 3–5 days. If a patient's warfarin dose is not reduced or INR is not monitored during clarithromycin treatment, the interaction can escalate from theoretical risk to clinical emergency.
Not all patients taking warfarin face equal risk when prescribed clarithromycin. Several factors increase vulnerability:
A 67-year-old woman with a history of atrial fibrillation has been stable on warfarin 5 mg daily for two years, with INR values consistently in the therapeutic range of 2.0–3.0. She presents to her primary care physician with a two-week cough, fever, and sputum production. A chest X-ray shows community-acquired pneumonia. Her physician prescribes clarithromycin 500 mg twice daily for seven days without directly communicating with the patient's anticoagulation clinic or pharmacist.
The patient fills both prescriptions and begins taking them simultaneously. By day four of clarithromycin therapy, the accumulating warfarin concentration begins to elevate her INR. She notices increased bruising on her arms and legs but attributes it to minor trauma. On day six, she experiences sudden severe abdominal pain and passes a dark, tarry stool—signs of gastrointestinal bleeding. She is rushed to the emergency department, where her INR is measured at 8.2 (well above the therapeutic range). She requires fresh frozen plasma transfusion, discontinuation of warfarin, and hospitalization. The interaction was entirely preventable with a simple phone call between her doctor and pharmacist, or by checking an interaction database before prescribing.
A 72-year-old man on warfarin 7 mg daily for mechanical heart valve replacement develops a skin infection (cellulitis) requiring antibiotics. His cardiologist is aware that clarithromycin can interact with warfarin. Rather than defaulting to clarithromycin, the cardiologist prescribes cephalexin (a beta-lactam antibiotic with no significant warfarin interaction). However, when the patient's insurance denies coverage for cephalexin, the covering physician agrees to prescribe clarithromycin instead—but only after the patient's INR is checked and found to be 2.5 (therapeutic). The clarithromycin is prescribed for five days, but the patient is explicitly told to return for INR rechecking within 48 hours.
At the 48-hour follow-up, the patient's INR has risen to 3.8. His warfarin dose is reduced from 7 mg to 5 mg daily. A second INR check is done 3–5 days later and comes back at 3.2—still slightly elevated but approaching therapeutic range. The clarithromycin course is completed, the reduced warfarin dose continues for another week, and then the INR stabilizes at 2.6. The patient avoids any bleeding complications because the interaction was anticipated, monitored, and actively managed.
If you take warfarin and your doctor wants to prescribe clarithromycin:
While on warfarin and clarithromycin together, seek immediate medical attention if you experience:
Contact your pharmacist or doctor (non-emergently) if you develop:
Do not restart warfarin or clarithromycin without explicit instruction from your doctor if you stop either medication.
Your medication safety depends on communication. Before you start any new antibiotic, cold medicine, herbal supplement, or over-the-counter drug while taking warfarin, verify the interaction at checkdruginteractions.com. Our comprehensive interaction checker is powered by over 250,000 FDA drug labels and gives you instant, evidence-based guidance on whether your medications are safe to combine. Check your full medication list today—it takes less than two minutes and could prevent a serious adverse event.
CDI checks every pair across up to 20 drugs — backed by FDA and NIH data.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
Methotrexate and ibuprofen have a major FDA-documented interaction. Learn mechanism, monitoring, and safe management strategies for healt...
Tacrolimus and fluconazole interaction explained. Learn severity, risks, and what FDA labels say about combining these drugs.
Is it safe to take methimazole and warfarin together? Learn about this drug interaction from FDA data and pharmacology.